Results

Total Results: 1,424 records

Showing results for "topical treatment".

  1. #14 SUBSTANCE ABUSE (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1412.pdf
    December 01, 2014 - Overall high-impact potential: Evzio for emergency treatment of opioid overdose by nonclinicians .. … new (and new uses of existing) pharmaceuticals, medical devices, diagnostic tests and procedures, therapeutic … purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures, treatments … , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … Medical treatment would be expected to be sought after administration of Evzio.
  2. Obesity (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/10_obesity_potential_high_impact_june_2012.pdf
    January 01, 2012 - new (and new uses of existing) pharmaceuticals, medical devices, diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … (Contrave ® , Orexigen Therapeutics, Inc., La Jolla, CA in collaboration with Takeda Pharmaceutical … New drug treatment options are needed for obese patients seeking medical therapy for weight loss. … Goods Administration for inclusion in its therapeutic goods registry for treating T2DM and obesity
  3. #14 SUBSTANCE ABUSE (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/14_substance_abuse_potential_high_impact_2012-12-11.pdf
    January 01, 2012 - new (and new uses of existing) pharmaceuticals, medical devices, diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … intervention to these therapies to improve a patient’s chances of successfully quitting. … in this report would compete with shorter-acting oral, sublingual, injectable, or patch-delivered therapies … About buprenorphine therapy. [internet].
  4. effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1306.pdf
    June 01, 2013 - new (and new uses of existing) pharmaceuticals, medical devices, diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address …  Key Facts: Before the approval of ivacaftor, therapies for CF had improved median survival times … Better treatments to prevent COPD exacerbations are needed. … Although the cost of azithromycin therapy would be additive to current treatment costs, its low cost
  5. effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1412.pdf
    December 01, 2014 - new (and new uses of existing) pharmaceuticals, medical devices, diagnostic tests and procedures, therapeutic … purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures, treatments … , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … 30% of patients achieve overall gout control, so a significant unmet need exists for more effective treatments … could be more expensive than existing options and patients who have trouble affording existing gout treatments
  6. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0278_03-10-2008.pdf
    January 01, 2008 - includes hand washing, in-hospital infection control, appropriate antibiotic prescribing, and effective treatment … Date: 6-2-09 2  The literature on this topic indicates that large studies with more standardized treatment … regimens are needed to evaluate the effectiveness of treatments for CDAD.
  7. effectivehealthcare.ahrq.gov/sites/default/files/06_devdelays_autism_potential_high_impact_june_2012.pdf
    January 01, 2012 - new (and new uses of existing) pharmaceuticals, medical devices, diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … Treatment for early intervention includes behavioral and communication therapies (including applied … archived from the horizon scanning system after expert comment processes include hyperbaric oxygen therapy … However, the efficacy of these treatments is unpredictable and varies widely, and when they do work
  8. PEPTIC ULCER #11 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1412.pdf
    December 01, 2014 - new (and new uses of existing) pharmaceuticals, medical devices, diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … ulcerative colitis), and we continue tracking novel drugs and interventions such as fecal microbiota therapy … No effective treatments are available to improve long-term nutritional absorption other than intestinal … at-home intravenous PN support for SBS, the manufacturer estimates the number of candidates for this therapy
  9. #05 DEPRESSION (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/depression_hi_impact.pdf
    October 01, 2014 - , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … DBS therapy is incompatible with some other device-based depression treatments. … psychotherapy (e.g., counseling), and family intervention as indicated; and considering ECT or alternative therapies … , counseling, family intervention, ECT) will likely remain as complementary therapies to ketamine, … New therapeutic promises in the treatment of depression and schizophrenia.
  10. effectivehealthcare.ahrq.gov/sites/default/files/dementia-horizon-scan-high-impact-1412.pdf
    February 01, 2015 - new (and new uses of existing) pharmaceuticals, medical devices, diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … We have identified and are currently monitoring multiple potential therapies with these properties, … Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central … Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot
  11. #05 DEPRESSION (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/05_depression_potential_high_impact_2012-12-10.pdf
    January 01, 2012 - Overall high-impact potential: deep brain stimulation (Reclaim DBS Therapy or Libra DBS) for treatment-resistant … and psychotherapy as first- and second-line therapies and electroconvulsive therapy or repetitive … treatments for treatment-resistant MDD, investigators have sought new approaches because available … DBS therapy is incompatible with some other device-based depression treatments. … Overall high-impact potential: deep brain stimulation (Reclaim DBS Therapy or Libra DBS) for treatment-resistant
  12. #05 DEPRESSION (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/05_depression_potential_high_impact_june_2012.pdf
    January 01, 2012 - Food and Drug Administration has not approved any therapies, is being explored. … third-line therapies for MDD, a proportion of patients affected by MDD have treatment-refractory disease … DBS therapy is incompatible with some other device-based depression treatments. … Menlo Park (CA): Corcept Therapeutics; [accessed 2011 Oct 18]. [2 p]. … Menlo Park (CA): Corcept Therapeutics; [accessed 2011 Oct 18]. [2 p].
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0283_03-10-2008.pdf
    January 01, 2008 - interested in the evidence base surrounding laparoscopic adjustable gastric banding (LAGB) for the treatment … Many recent studies on the effectiveness of bariatric surgery for the treatment of diabetes have shown … bariatric surgery to be more effective in treating type 2 diabetes than conventional therapy. … bariatric surgery, such as a less invasive laparoscopic gastric banding, should be the first-line treatment
  14. effectivehealthcare.ahrq.gov/sites/default/files/dementia-horizon-scan-high-impact-1312.pdf
    December 01, 2013 - purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures, treatments … , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … Experts commenting on this intervention agreed that the need for disease-modifying treatments for AD … Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease. … Insulin: compare common options for insulin therapy. [internet].
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-intro.ppt
    June 01, 2012 - as well as scored questionnaires intended for screening or to assess likely prognosis or response to therapy … Conversely, most treatments lead directly to intended results or adverse effects. … Reprinted with corrections and an updated topical bibliography in 1988 (Los Altos, CA: Peninsula Publishing … It has proven useful for evaluating therapies and can also be applied to the evaluation of medical tests … Reprinted in 1988 with corrections and an updated topical bibliography (Los Altos, CA: Peninsula Publishing
  16. effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-intro.ppt
    June 01, 2012 - as well as scored questionnaires intended for screening or to assess likely prognosis or response to therapy … Conversely, most treatments lead directly to intended results or adverse effects. … Reprinted with corrections and an updated topical bibliography in 1988 (Los Altos, CA: Peninsula Publishing … It has proven useful for evaluating therapies and can also be applied to the evaluation of medical tests … Reprinted in 1988 with corrections and an updated topical bibliography (Los Altos, CA: Peninsula Publishing
  17. effectivehealthcare.ahrq.gov/sites/default/files/topic-refinement.ppt
    March 01, 2010 - Beliefs about the advantages or disadvantages of various alternative treatments are an important target … , another active therapy, or no control therapy O — Pulmonary variables, anthropometrics, bone variables … Control therapies we would accept were placebo, no therapy, another active therapy, or no control therapy … duration, baseline nutritional status, and concurrent medical therapies? … duration, baseline nutritional status, and concurrent medical therapies?
  18. effectivehealthcare.ahrq.gov/sites/default/files/06_devdelays_potential_high_impact_2012-12-10.pdf
    January 01, 2012 - new (and new uses of existing) pharmaceuticals, medical devices, diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … Early-intervention treatment includes behavior and communication therapies (including applied behavior … archived from the horizon scanning system after expert comment processes include hyperbaric oxygen therapy … STX209 (arbaclofen, Seaside Therapeutics, Cambridge, MA) is a gamma aminobutyric acid (GABA)-B agonist
  19. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0316_03-12-2009.pdf
    January 01, 2009 - It can also be used to adjust anti-hypertensive drug therapy and reduce clinic visits with patients. … What is the effect of treatment guided by SMBP in comparison to treatment guided by clinic BP, in terms … Use of anti-hypertensive drug therapy iv. BP control 3. … What is the effect of treatment guided by ABP in comparison to treatment guided by clinic BP, in terms … Use of anti-hypertensive drug therapy iv. BP control 4.
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-2.pdf
    June 01, 2022 - Acute Treatment for Episodic Migraine: Surveillance Report 2 Acute Treatments for Episodic Migraine … , usual care, attention control, and no treatment up to 4 weeks after treatments (KQ 3). … What are the effects of prescribing opioid therapy versus not prescribing opioid therapy for acute treatment … invasive treatments (surgical interventions, etc.), and preventive (prophylactic) treatment … , nonpharmacologic therapy KQ3: Sham treatment, waitlist, usual care, attention control, and no treatment

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: